Bicycle Therapeutics (BCYC) Treasury Shares (2018 - 2026)

Bicycle Therapeutics' Treasury Shares history runs 7 years deep, the most recent figure standing at $2.8 million for Q1 2026.

• Quarterly Treasury Shares rose 45.12% year-over-year to $2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (up 45.12% YoY) and the FY2025 annual result came in at $1.5 million, up 129.46% from the prior year.
• Treasury Shares was $2.8 million for Q1 2026 at Bicycle Therapeutics, up from $1.5 million in the prior quarter.
• Across five years, Treasury Shares topped out at $2.8 million in Q1 2026 and bottomed at $187725.0 in Q1 2022.
• A 5-year average of $891627.2 and a median of $674262.0 in 2024 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2023 — Treasury Shares soared 141.08% — and 2026, when it jumped 45.12%.
• Bicycle Therapeutics' Treasury Shares stood at $187725.0 in 2022, then soared by 74.11% to $326848.0 in 2023, then jumped by 106.29% to $674262.0 in 2024, then surged by 129.46% to $1.5 million in 2025, then soared by 79.81% to $2.8 million in 2026.
• Business Quant data shows BCYC's Treasury Shares at $2.8 million in Q1 2026, $1.5 million in Q4 2025, and $1.7 million in Q3 2025.